Keyphrases
21st Century
22%
7-nitroindazole
22%
Age Impact
22%
Benign Epilepsy
22%
Benign Familial Infantile Epilepsy
22%
Blood Flow
22%
Brain Development
29%
Brain Injury
95%
Brain Regions
24%
Cell Death
22%
Cerebral Hemispheres
36%
Cerebral Hyperemia
22%
Cerebral Metabolism
22%
Child Sleep
45%
Comorbid
22%
Developing Rat Brain
32%
Diagnostic Imaging
22%
Excitotoxic
37%
Gene Delivery
22%
High-risk Infants
22%
Hypoxia-ischemia
47%
Hypoxic-ischemic Brain Injury
100%
Hypoxic-ischemic Encephalopathy
26%
Immature Rats
61%
Ionotropic
26%
Laboratory Model
30%
Lesion Size
22%
N-methyl-D-aspartate
54%
N-methyl-D-aspartic Acid
22%
N-methyl-D-aspartic Acid Receptor
22%
Neonatal Rats
68%
Neuronal Damage
22%
Neuronal Injury
47%
Neuronal Nitric Oxide Synthase (nNOS)
30%
Neurotoxicity
42%
Neurotoxin
24%
Newborn Lambs
45%
Occlusion
32%
Pathophysiology
24%
Pharmacology
24%
Postnatal Day
46%
Premature Infant
22%
Quinolinate
43%
Quisqualate
45%
Rat Brain
27%
Receptor Agonist
26%
Respiratory-related Evoked Potential
45%
Seizure
58%
Severe Hypoxemia
22%
Synaptic Dysfunction
22%
Neuroscience
7-Nitroindazole
22%
Amblyopia
22%
AMPA
45%
AMPA Receptor
29%
Antiseizure Medication
22%
Aspartic Acid
37%
Benign Epilepsy
15%
Biochemical Cascade
22%
Brain Injury
38%
Brain Ischemia
49%
Brain Tumor
22%
CD1 Antigen
22%
Cerebral Cortex
15%
Cognitive Disorders
15%
Dextro Aspartic Acid
45%
Evoked Potential
48%
Excitotoxicity
40%
Fragile X Syndrome
22%
Gene Delivery
22%
Glutamic Acid
15%
Hydrocephalus
11%
Hypothermia
30%
Intractable Epilepsy
15%
Ischemia
49%
Ketogenic Diet
45%
Methyldienolone
22%
N-Methyl-D-Aspartic Acid
22%
Narcolepsy
22%
Neuronal Nitric Oxide Synthase
32%
Neuroprotective Agent
26%
Neuroscience
22%
Neurotoxin
24%
Nitric Oxide Synthase
30%
Obstructive Sleep Apnea
22%
Pediatric Epilepsy
22%
Pediatric Neurology
22%
Pervasive Developmental Disorder
22%
Quisqualic Acid
16%
Receptor Agonists
27%
Slow-Wave Sleep
37%
Social Behavior
22%
Speech Recognition
17%
Status Epilepticus
30%
Strabismus
22%
Striatum
31%
Thalamus
22%
Tourette Syndrome
22%
Visual Cortex
11%
Visual Evoked Potential
22%
Medicine and Dentistry
Adverse Effect
11%
Aphasia
7%
Apoplexy
10%
Aspartic Acid
22%
Benign Childhood Epilepsy
22%
Benign Epilepsy
22%
Benzodiazepine Derivative
7%
Blood Flow
11%
Brain Blood Flow
21%
Brain Imaging
11%
Brain Metabolism
11%
Cell Death
11%
Central Nervous System Disease
22%
Clinical Syndrome
7%
Cognitive Defect
15%
Color Doppler Flowmetry
9%
Deterioration
7%
Disease
30%
EEG Abnormality
11%
Epileptic Seizure
30%
Excitotoxicity
15%
Gilles De La Tourette Syndrome
22%
Glia
7%
Glutamate Neurotransmitter
7%
Hemodynamic
22%
High Risk Infant
11%
High Risk Population
11%
Hyperaemia
32%
Hypoxemia
11%
Ischemia
34%
Ischemic Injury
27%
Medication Compliance
22%
Midbrain
9%
N-Methyl-D-Aspartic Acid
22%
Neonatal Infant
22%
Neurotransmitter Receptor
7%
Oligodendroglia
7%
Orphan Disorder
7%
Pathophysiology
11%
Pediatric Neurology
22%
Pediatrics
22%
Pediatrics Patient
7%
Prematurity
11%
Slow-Wave Sleep
22%
Sodium Valproate
7%
Spastic Diplegia
15%
Status Epilepticus
30%
Stereotypic Movement Disorder
7%
Toddlers
7%